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Abstract 
It suggests that non-surgical periodontal therapy without systemic antibiotic therapy may not achieve 
a significant improvement in glycemic control and systemic inflammation in diabetic patients. 
However, it is important to highlight that the decision of whether or not to use antibiotics to treat 
periodontitis. Thus this study aimed to evaluate over 3 months the consequence of non-surgical 
periodontal treatment without systemic antibiotic therapy on serum levels of HbA1c and C-reactive 
protein (CRP). Forty-two participants with type 2 diabetes mellitus (DM) and moderate periodontal 
disease were randomized into intervention (IG) and control (CG) groups. The IG received non-surgical 
periodontal therapy in the form of full-mouth scaling and root planing. Participants were followed up 
for 3 months. The CG received non-surgical periodontal therapy after 3 months. Clinical parameters, 
including plaque index (PI), gingival bleeding index (GBI), probing pocket depth (PPD), clinical 
attachment level (CAL), and HbA1c and CRP levels, of all patients were recorded at baseline and after 
3 months. A p-value less than 0.05 considered significant. At the end of 3 months, IG showed 
improvement in all the clinical parameters compared to CG. There were no significant differences in 
HbA1c and CRP after 3 months when compared to the baseline level in both groups. Clinical parameters 
were significantly improved by the employment of non-surgical periodontal treatment without systemic 
antibiotic therapy, but HbA1C and CRP levels were not significantly affected. 
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1. Introduction 
Diabetes is a chronic disease that affects 8.5% of 
the world's population. It is estimated that by 2040, 
the number of people with the disease will increase to 
642 million worldwide. Based on the epidemiological 
studies it is estimated that in the year 2030 nearly 9.2 
million Iranians likely to have diabetes [1].  
It has been described that periodontal disease is 
the sixth complication of diabetic patients after 
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diabetic nephropathy, neuropathy, retinopathy, 
vascular disease, and delayed healing [2]. Periodontitis 
is a chronic inflammatory disease that causes 
progressive damage of periodontium and leading to 
tooth loss. It is associated with an undesirable 
impression on the patient's quality of life [3]. The 
production of pro-inflammatory mediators such as 
and C-1 reactive protein (CRP) in patients with 
periodontitis is increased. All these mediators can 
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cause insulin resistance and also alter the lipid and 
glucose metabolism [4]. Glycosylated haemoglobin 
(HbA1c) forms by irreversible binding of glucose to 
haemoglobin. HbA1c levels represent glycaemic 
control over the previous 1-3 months [5]. Thus, 
periodontal disease can affect HbA1c and CRP levels in 
diabetic patients [4].  
One of the most common therapy that used for the 
treatment of periodontitis is scaling and root planing. 
Although scaling and root planing improves the 
periodontal status in the majority of patients, it is 
usually insufficient to alter the bacterial profile 
followed by periodontal status [6]. The aim of systemic 
periodontal antibiotic therapy is to killing subgingival 
pathogens that remain after conventional mechanical 
periodontal therapy to support mechanical 
periodontal therapy and the host defense system [7]. It 
suggests that in patients with a long history of diabetes, 
the conventional periodontal therapy alone cannot 
achieve a significant improvement in glycemic control 
and systemic inflammation [7-9]. However, it is 
important to highlight that improper administration 
of antibiotics can lead to side effects of various 
intensities, and their indiscriminate use might lead to 
the tolerance to the antibiotics [10]. Therefore, the 
need to use or not to use these agents by dentists can 
be a challenge. Thus, this study aimed to evaluate the 
consequence of non-surgical periodontal therapy 
without systemic antibiotic treatment on serum levels 
of HbA1c and CRP over 3 months. 
 
2. Materials and Methods 
2.1 Study population 
This study received ethics approval by Guilan 
University of Medical Sciences (Approval code: 
IR.GUMS.REC.1398.307). Also, the clinical trial 
protocol was registered (IRCT registration number: 
IRCT20190721044287N1) and available online. The 
study population consisted of 42 participants with type 
2 DM (HbA1c ≥ 7%). Inclusion criteria included the 
following: 1) Patients with chronic periodontitis who 
received no periodontal treatment in the past 6 
months; 2) Receiving periodontal and antibiotic 
treatments during the last 6 months; 3) Patients with 
at least 14 teeth in the mouth and a pocket depth (PD) 
≥ 5 mm in at least four areas and 4 ≥ clinical 
attachment level (CAL) ≥ 3 mm in at least four areas; 
4) Diabetes diagnosed by a physician for the past 6 
months; 5) Patients with unchanged diabetic 
medication for the past 3 months. Exclusion criteria 
included: 1) Patients with advanced diabetic problems 
(macrovascular and microvascular); 2) Chronic 
pulmonary disease; 3) Kidney and liver diseases; 4) 
Malignancies; 5) Heart disease (coronary artery 
disease); 6) Transplanted patients; 7) History of 
infection and trauma; 8) Alcoholic and smoker 




In this study, using a computer program, 
participants were randomized into two groups of 21 
each: the intervention group (IG) and the control 
group (CG). All the patients received health education 
using toothbrush and toothpaste with a modified bass 
method twice a day, and dental floss and chlorhexidine 
mouthwash (0.12%) twice a day. The IG received non-
surgical periodontal therapy in the form of full-mouth 
scaling and root planing in two sessions, 1 week apart, 
with the use of slim instruments, under local 
anesthesia. Participants were followed up for 3 
months. The CG received non-surgical periodontal 
therapy after 3 months. 
 
2.3 Follow up 
During 3 months of follow up, patients with the 
following criteria were excluded from the study: 1) 
Patients with diabetic diet changes during the study 
period; 2) Patients with problems requiring 
emergency treatment; 3) Patients who changed their 
diets or medications or used antibiotics during the 
study. 
 
2.4 Data collection 
Clinical parameters, including plaque index (PI), 
gingival index (GI), gingival bleeding index (GBI), 
probing pocket depth (PPD), CAL were examined at 
baseline and after 3 months. Patients’ blood samples 
were obtained from the Razi Laboratory at 8.5-11 A.M. 
to assess their HbA1c and CRP levels at baseline and 
after 3 months. 
 
2.5 Statistical analysis 
Data was compiled and analyzed through SPSS 
version 24. Quantitative variables like HbA1c and CRP 
were presented as mean ± SD. The Pearson test was 
used to test the correlation of the periodontal 
parameters with HbA1C and CRP levels, and the 
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correlation of serum level of HbA1C with CRP level. 
Differences among all variables from baseline to the 3-
month visit were analyzed using the Wilcoxon Mann-
Whitney U test because it was not normally 
distributed. The linear regression test was used to 
evaluate the effect of age and gender on the HbA1C and 
CRP levels. A p-value <0.05 considered significant. 
 
3. Results 
HbA1c and CRP levels in the CG and IG at baseline 
and after 3 months are shown in Table 1 and Table 2, 
respectively. Table 3 showed HbA1c and CRP levels 
changes between baseline and after 3 months. Based 
on the results of the present study, the two groups did 
not differ significantly in the HbA1C (Table 1) and CRP 
(Table 2) levels at baseline. Also, the results indicated 
that age and gender did not significantly affect the 
HbA1C and CRP levels at baseline. 
The results indicated that all periodontal 
parameters measured (PI, GI, GBI, PPD, and CAL) 
showed improvement after 3 months of non-surgical 
periodontal treatment in the IG compared to the CG 
(Table 4). 
Based on the result of the present study, the 
relation between HbA1C (Table 5) and CRP (Table 6) 
1with periodontal parameter changes was not 
statistically significant. 
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Discussion  
Based on the result of the present study, non-
surgical periodontal therapy without systemic 
antibiotic therapy could improve the periodontal 
status of patients with type 2 DM. Similar to the result 
of the present study, Vaghani et al. showed scaling, 
and root planing is associated with significant 
reductions in the GI, Oral Health Index (OHI-S), PPD, 
and CAL levels of patients with periodontitis [4]. These 
findings are similar to a study done by Obeid et al., 
which showed the effectiveness of scaling and root 
planing in improving the periodontal status of patients 
with periodontitis [11].  
Based on the results of the present study, non-
surgical periodontal therapy without systemic 
antibiotic therapy did not affect the serum level of 
HbA1C. Similarly, a study done by Aldridge et al. 
reported a significant improvement in periodontal 
parameters after scaling and root planing without 
systemic antibiotic therapy but did not found any 
improvement in HbA1c levels in 22 patients with type 
1 diabetes and severe periodontitis [9]. Grossi et al. 
Table 4. Differences of periodontal parameters in intervention group (IG) compared to control group 




Statistic P value CG 
(Mean Difference ± SD) 
IG 
(Mean Difference  ± SD) 
PI 16.89 ± -4.95 8.16 ± -40.62 4.70 <0.001 
GI 0.12 ± 0.08 0.28 ± -0.88 5.61 <0.001 
PD 0.15 ± 0.07 0.55 ± - 1.10 5.60 <0.001 
CAL 0.15 ± 0.03 0.31 ± - 0.50 5.24 <0.001 
GBI 8.41 ± 0.19 19.01 ± -46.24 5.04 <0.001 
 




Table 5. Relationships between periodontal parameters and HbA1c serum level 
changes in the control group (CG) and intervention group (IG) after 3 months 
 
Group Subgroup PI GI PD CAL GBI 
CG 
>9  HbA1c 
r = 0.06 
p = 0.820 
r = -0.26 
p = 0.342 
r = 0.04 
p = 0.869 
r = -0.23 
p = 0.39 
r = 0.23 
p = 0.410 
≤9  HbA1c 
r = 0.47 
p = 0.340 
r = -0.25 
p = 0.633 
r = 0.24 
p = 0.641 
r = -0.61 
p = 0.191 
r = 0.69 
p = 0.125 
IG 
>9HbA1c 
r = - 0.36 
p = 0.182 
r = -0.23 
p = 0.409 
r = 0.05 
p = 0.851 
r = -0.27 
p = 0.329 
r = -0.06 
p = 0.831 
≤9  HbA1c 
r = -0.50 
p = 0.313 
r = 0.51 
p = 0.313 
r = 0.01 
p = 0.984 
r = -0.58 
p = 0.222 
r = -0.19 
p = 0.718 
 




Table 6. Relationships between periodontal parameters and CRP serum 
level changes in the control group (CG) and intervention group (IG) 
after 3 months 
 
Group PI GI PD CAL GBI 
CG 
r = -0.20 
p = 0.383 
r = - 0.32 
p = 0.158 
r = 0.10 
p = 0.679 
r = - 0.04 
p = 0.876 
r = 0.007 
p = 0.976 
IG 
r = -0.23 
p = 0.318 
r = - 0.24 
p = 0.299 
r = -0.20 
p = 0.381 
r = -0.20 
p = 0.393 
r = 0.36 
p = 0.109 
 
Plaque index (PI), Gingival index (GI), Pocket depth (PD), Clinical attachment level (CAL), Gingival bleeding index (GBI)   
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indicated that that topical antimicrobial and systemic 
doxycycline along with mechanical therapy (100 
mg/day for 14 days) resulted in a significant gain in 
attachment level and a reduction of almost 1% in the 
levels of HbAlc at 3 months after treatment [12]. 
Another study conducted by Singh et al. showed that 
non-surgical periodontal treatment followed by 
systemic doxycycline is associated with improved 
glycaemic control in type 2 diabetic patients [10]. This 
may be due to their antimicrobial effects. 
Based on the results of the present study, non-
surgical periodontal therapy without systemic 
antibiotic therapy did not affect the serum level of 
CRP. Similarly, in a study, non-surgical periodontal 
therapy without systemic antibiotic therapy did not 
affect the serum level of high‐sensitivity C‐reactive 
protein (hsCRP) in Sixty participants with type 2 DM 
and moderate to severe periodontal disease [8]. Also, 
Katagiri et al. evaluated the effects of periodontal 
treatment simultaneously on both A1c and CRP levels 
in DM [13]. In that study of 49 participants, scaling and 
root planing plus topical treatment with minocycline 
ointment showed no effect on hsCRP levels after 6 
months. 
It seems that the clinical beneficial results 
achieved with non-surgical periodontal treatment in 
the short-term are frequently not maintained in the 
long term, particularly in more advanced cases [6] or 
in those associated with risk factors, such as smoking 
[14] and diabetic patients [15], because of tolerance to 
the treatment observed in the case of smokers, or due 
to the higher prevalence of severe periodontitis 
observed in patients with diabetes mellitus [5, 15]. For 
this reason, it has been suggested that the 
administration of systemic antibiotics can be used 
together with scaling and root planing. 
The limitations of the study were the small sample 
size. Also, serum levels of pro-inflammatory mediators 
such as TNF-α, IL-1 β, IL-6 were not measured. In 
conclusion, there is a need for more randomized 
controlled clinical trials with larger sample sizes, long-
term follow-ups, and strict adjustments for 
confounding factors, such as age, gender, body mass 
index (BMI), race/ethnicity, and smoking status to 
confirm the findings of this study 
Despite the improvement of clinical parameters 
after three months of non-surgical treatment due to no 
change in important serological markers associated 
with inflammatory disease and there is a possibility of 
disease progression and re-alteration of clinical 
parameters, it is suggested that antibiotic therapy 
should be used as adjunctive therapy.  
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